Original Report| Volume 32, ISSUE 6, P605-611, December 2019

A Management Protocol for Gonad Preservation in Patients with Androgen Insensitivity Syndrome


      Historically, individuals with androgen insensitivity syndrome (AIS) were managed with removal of gonadal tissue at various ages to avert the risk of gonadal malignancy. Recently, clinical practice changed, with gonadectomy being postponed until late adolescence. Adolescents and adults with complete AIS have questioned this approach. Additionally, testicular germ cell tumors are increasingly believed to be quite rare with rates as low as 0% in molecularly confirmed individuals with AIS. Gonadectomy deprives patients of the benefits of their endogenous hormones and potential fertility. Furthermore, human rights organizations advocate for deferring irreversible surgery in conditions known as differences of sex development, which includes AIS, to allow patient autonomy in decision-making. Recent literature supports an approach that uses risk stratification to manage gonads in AIS. Herein we review what is known about malignancy risk in the different subtypes of AIS and propose a management protocol for gonad retention.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hughes I.A.
        • Morel Y.
        • McElreavey K.
        • et al.
        Biological assessment of abnormal genitalia.
        J Pediatr Urol. 2012; 8: 592
        • Deans R.
        • Creighton S.M.
        • Liao L.M.
        • et al.
        Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence.
        Clin Endocrinol. 2012; 76: 894
        • Cools M.
        • Wolffenbuttel K.P.
        • Hersmus R.
        • et al.
        Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
        Hum Reprod. 2017; 32: 2561
        • Patel V.
        • Casey R.K.
        • Gomez-Lobo V.
        Timing of gonadectomy in patients with complete androgen insensitivity syndrome-current recommendations and future directions.
        J Pediatr Adolesc Gynecol. 2016; 29: 320
        • Hughes I.A.
        • Deeb A.
        Androgen resistance.
        Best Pract Res Clin Endocrinol Metab. 2006; 20: 577
        • Oakes M.B.
        • Eyvazzadeh A.D.
        • Quint E.
        • et al.
        Complete androgen insensitivity syndrome--a review.
        J Pediatr Adolesc Gynecol. 2008; 21: 305
        • Morris J.M.
        The syndrome of testicular feminization in male pseudohermaphrodites.
        Am J Obstet Gynecol. 1953; 65: 1192
        • Quigley C.A.
        • De Bellis A.
        • Marschke K.B.
        • et al.
        Androgen receptor defects: historical, clinical, and molecular perspectives.
        Endocr Rev. 1995; 16: 271
        • Bangsboll S.
        • Qvist I.
        • Lebech P.E.
        • et al.
        Testicular feminization syndrome and associated gonadal tumors in Denmark.
        Acta Obstet Gynecol Scand. 1992; 71: 63
        • Boehmer A.L.
        • Brinkmann O.
        • Bruggenwirth H.
        • et al.
        Genotype versus phenotype in families with androgen insensitivity syndrome.
        J Clin Endocrinol Metab. 2001; 86: 4151
        • Mazen I.
        • El-Ruby M.
        • Kamal R.
        • et al.
        Screening of genital anomalies in newborns and infants in two egyptian governorates.
        Horm Res Paediatr. 2010; 73: 438
        • Cools M.
        • Drop S.L.
        • Wolffenbuttel K.P.
        • et al.
        Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers.
        Endocr Rev. 2006; 27: 468
        • Looijenga L.H.
        • Hersmus R.
        • Oosterhuis J.W.
        • et al.
        Tumor risk in disorders of sex development (DSD).
        Best Pract Res Clin Endocrinol Metab. 2007; 21: 480
        • Kravarusic D.
        • Seguier-Lipszyc E.
        • Feigin E.
        • et al.
        Androgen insensitivity syndrome: risk of malignancy and timing of surgery in a paediatric and adolescent population.
        Afr J Paediatr Surg. 2011; 8: 194
        • Dewhurst C.J.
        • Ferreira H.P.
        • Gillett P.G.
        Gonadal malignancy in XY females.
        J Obstet Gynaecol Br Commonw. 1971; 78: 1077
        • Liu A.X.
        • Shi H.Y.
        • Cai Z.J.
        • et al.
        Increased risk of gonadal malignancy and prophylactic gonadectomy: a study of 102 phenotypic female patients with Y chromosome or Y-derived sequences.
        Hum Reprod. 2014; 29: 1413
        • Cools M.
        • Looijenga L.
        Update on the pathophysiology and risk factors for the development of malignant testicular germ cell tumors in complete androgen insensitivity syndrome.
        Sex Dev. 2017; 11: 175
        • Kaprova-Pleskacova J.
        • Stoop H.
        • Bruggenwirth H.
        • et al.
        Complete androgen insensitivity syndrome: factors influencing gonadal histology including germ cell pathology.
        Mod Pathol. 2014; 27: 721
        • Manuel M.
        • Katayama P.K.
        • Jones Jr., H.W.
        The age of occurrence of gonadal tumors in intersex patients with a Y chromosome.
        Am J Obstet Gynecol. 1976; 124: 293
        • Verp M.S.
        • Simpson J.L.
        Abnormal sexual differentiation and neoplasia.
        Cancer Genet Cytogenet. 1987; 25: 191
        • Muller J.
        Morphometry and histology of gonads from twelve children and adolescents with the androgen insensitivity (testicular feminization) syndrome.
        J Clin Endocrinol Metab. 1984; 59: 785
        • Hurt W.G.
        • Bodurtha J.N.
        • McCall J.B.
        • et al.
        Seminoma in pubertal patient with androgen insensitivity syndrome.
        Am J Obstet Gynecol. 1989; 161: 530
        • Rutgers J.L.
        • Scully R.E.
        The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases.
        Int J Gynecol Pathol. 1991; 10: 126
        • Hannema S.E.
        • Scott I.S.
        • Rajpert-De Meyts E.
        • et al.
        Testicular development in the complete androgen insensitivity syndrome.
        J Pathol. 2006; 208: 518
        • Purves J.T.
        • Miles-Thomas J.
        • Migeon C.
        • et al.
        Complete androgen insensitivity: the role of the surgeon.
        J Urol. 2008; 180: 1716
        • Morris J.M.
        • Mahesh V.B.
        Further observations on the syndrome, “testicular feminization”.
        Am J Obstet Gynecol. 1963; 87: 731
        • Dewhurst C.J.
        The XY female.
        Am J Obstet Gynecol. 1971; 109: 675
        • Ahmed S.F.
        • Cheng A.
        • Dovey L.
        • et al.
        Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
        J Clin Endocrinol Metab. 2000; 85: 658
        • van der Zwan Y.G.
        • Biermann K.
        • Wolffenbuttel K.P.
        • et al.
        Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model.
        Eur Urol. 2015; 67: 692
        • Wisniewski A.B.
        • Migeon C.J.
        • Meyer-Bahlburg H.F.
        • et al.
        Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome.
        J Clin Endocrinol Metab. 2000; 85: 2664
        • Birnbaum W.
        • Bertelloni S.
        Sex hormone replacement in disorders of sex development.
        Endocr Dev. 2014; 27: 149
        • Pearce C.L.
        • Stram D.O.
        • Ness R.B.
        • et al.
        Population distribution of lifetime risk of ovarian cancer in the United States.
        Cancer Epidemiol Biomarkers Prev. 2015; 24: 671
        • National Cancer Institute
        Surveillance, Epidemiology, and End Results Program: Cancer stat facts: ovarian cancer.
        • Parker W.H.
        • Broder M.S.
        • Chang E.
        • et al.
        Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study.
        Obstet Gynecol. 2009; 113: 1027
        • Parker W.H.
        Bilateral oophorectomy versus ovarian conservation: effects on long-term women’s health.
        J Minim Invasive Gynecol. 2010; 17: 161
        • Han T.S.
        • Goswami D.
        • Trikudanathan S.
        • et al.
        Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis.
        Eur J Endocrinol. 2008; 159: 179
        • Soule S.G.
        • Conway G.
        • Prelevic G.M.
        • et al.
        Osteopenia as a feature of the androgen insensitivity syndrome.
        Clin Endocrinol. 1995; 43: 671
        • King T.F.J.
        • Wat W.Z.M.
        • Creighton S.M.
        • et al.
        Bone mineral density in complete androgen insensitivity syndrome and the timing of gonadectomy.
        Clin Endocrinol. 2017; 87: 136
        • Schweizer K.
        • Brunner F.
        • Gedrose B.
        • et al.
        Coping with diverse sex development: treatment experiences and psychosocial support during childhood and adolescence and adult well-being.
        J Pediatr Psychol. 2017; 42: 504
        • Finlayson C.
        • Johnson E.K.
        • Chen D.
        • et al.
        Proceedings of the Working Group Session on Fertility Preservation for Individuals with Gender and Sex Diversity.
        Transgend Health. 2016; 1: 99
        • Campo-Engelstein L.
        • Chen D.
        • Baratz A.B.
        • et al.
        The ethics of fertility preservation for pediatric patients with differences (disorders) of sex development.
        J Endocr Soc. 2017; 1: 638
        • Tordjman K.M.
        • Yaron M.
        • Berkovitz A.
        • et al.
        Fertility after high-dose testosterone and intracytoplasmic sperm injection in a patient with androgen insensitivity syndrome with a previously unreported androgen receptor mutation.
        Andrologia. 2014; 46: 703
        • Massin N.
        • Bry H.
        • Vija L.
        • et al.
        Healthy birth after testicular extraction of sperm and ICSI from an azoospermic man with mild androgen insensitivity syndrome caused by an androgen receptor partial loss-of-function mutation.
        Clin Endocrinol. 2012; 77: 593
        • O’Malley A.S.
        • Carrier E.R.
        • Docteur E.
        • et al.
        Policy Options to Encourage Patient-Physician Shared Decision Making, No. 5.
        National Institute for Health Care Reform, Washington, DC2011
        • Sexual Health
        Human Rights and the Law.
        WQ200, Geneva, Switzerland2015
      1. UNFE Intersex Fact Sheet.
        in: Equal UNF. United Nations Human Rights Office, Office of the High Commissioner, Geneva, Switzerland2015: 1-2
      2. Lambda Legal. Providing ethical and compassionate health care to intersex patients: Intersex-affirming hospital policies. 2018 (Available from:)
        • Strangio C.
        Stop performing nonconsensual, medically unnecessary surgeries on young intersex children.
        ACLU, LGBT & HIV Project, New York, NY2017
      3. “I want to be like nature made me”: medically unnecessary surgeries on intersex children in the US. Human Rights Watch, New York, NY2017
      4. In recognition of intersex awareness day [press release]. US Department of State, Washington, DC2017
        • Harris P.
        Supporting autonomy for patients with differences of sex development (DSD) (Resolution 3-A-16).
        American Medical Association, Chicago, IL2016
        • Tasian G.E.
        • Copp H.L.
        • Baskin L.S.
        Diagnostic imaging in cryptorchidism: utility, indications, and effectiveness.
        J Pediatr Surg. 2011; 46: 2406
        • Nakhal R.S.
        • Hall-Craggs M.
        • Freeman A.
        • et al.
        Evaluation of retained testes in adolescent girls and women with complete androgen insensitivity syndrome.
        Radiology. 2013; 268: 153
        • Verma K.
        • Ram T.R.
        • Kapila K.
        Value of fine needle aspiration cytology in the diagnosis of testicular neoplasms.
        Acta Cytol. 1989; 33: 631
        • Heikkila R.
        • Heilo A.
        • Stenwig A.E.
        • et al.
        Testicular ultrasonography and 18G biopty biopsy for clinically undetected cancer or carcinoma in situ in patients with germ cell tumours.
        Br J Urol. 1993; 71: 214
        • Capelouto C.C.
        • Clark P.E.
        • Ransil B.J.
        • et al.
        A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary?.
        J Urol. 1995; 153: 981
        • Griffin N.
        • Grant L.A.
        • Freeman S.J.
        • et al.
        Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique?.
        Eur Radiol. 2009; 19: 230
        • Shaida N.
        • Berman L.H.
        Percutaneous testicular biopsy for indeterminate testicular lesions.
        Br J Radiol. 2012; 85: S54